comparemela.com
Home
Live Updates
Tolvaptan use tied to changes in mineral metabolism parameters and increased BMD in polycystic kidney disease : comparemela.com
Tolvaptan use tied to changes in mineral metabolism parameters and increased BMD in polycystic kidney disease
Switzerland: Chronic treatment with Tolvaptan is tied to an increased femoral bone mineral density (BMD), and remarkable changes in both acid-base parameters and mineral metabolism in patients with...
Related Keywords
Bern ,
Switzerland ,
Bruno Vogt ,
Matteo Bargagli ,
Nicolas Faller ,
Danielg Fuster ,
Andri Vetsch ,
Manuela Anderegg ,
Duyen Huynh ,
Nassera Dhayat ,
Pietro Manuel Ferraro ,
University Of Bern ,
Uyen Huynh Do ,
Nephrology Dialysis Transplantation ,
Bone Mineral Density ,
Mineral Metabolism ,
Olvaptan ,
Autosomal Dominant Polycystic Kidney Disease ,
Adpkd ,
Demoral ,
Chronic Treatment ,
Henotype ,
Polycystic Kidney Disease ,
comparemela.com © 2020. All Rights Reserved.